Systemic Monoclonal Antibody Therapy (Daclizumab) in the Treatment of Cicatrizing Conjunctivitis in Stevens-Johnson Syndrome, Refractory to Conventional Therapy

Author: Fiorelli Vanessa M. B.   Dantas Paulo E. C.   Jackson Allen T.   Nishiwaki-Dantas M. Cristina  

Publisher: Informa Healthcare

ISSN: 0271-3683

Source: Current Eye Research, Vol.35, Iss.12, 2010-12, pp. : 1057-1062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract